Drug Targets – News and Features
News
BioTrove and SPRI Expand Lead Discovery Collaboration
BioTrove will use its RapidFire® Lead Discovery service for assay development and high throughput screening.
News
ActiveSight to Provide Crystallography Services to Inpharmatica
The agreement focuses on co-crystallography by ActiveSight of certain Inpharmatica small molecules.
News
Myriad Genetics and Abbott Extend Collaboration
Abbott will fund the research and Myriad will use its high-throughput sequencing technologies to analyze samples.
News
DxS Launches Bespoke Consultancy and Training Service
Pharmaceutical and clinical research customers can receive training on pharmacogenomics and personalized medicine.
News
Genizon BioSciences Licenses Ingenuity Pathways Analysis 3.0
Genizon will integrate the newest release of Ingenuity Pathways Analysis into its Target Express platform.
News
Structure of Key Cancer Drug Target Identified
Researchers have determined the structure of the protein JAK2 kinase.
News
Monogram and Merck to Conduct Erbitux® Biomarker Study
Monogram will test formalin-fixed, paraffin-embedded (FFPE) tumor samples from patients with colorectal cancer.
News
Oxford Genome Sciences Licences OGAP Database to UCB
UCB has capitalised on the potential of OGAP database to enhance their drug discovery efforts.
News
Inpharmatica Licenses Biopendium™ to Schering
The aim of collaboration is to prioritise proteins as drug targets.
News
Galapagos Featured in Leading Drug Discovery Journal
The paper gives insight into how Galapagos applies its RNA interference technology.
Advertisement
